Literature DB >> 23182761

Interleukin-37 is elevated in subjects with atopic dermatitis.

Hiroyuki Fujita, Yusuke Inoue, Katsuya Seto, Noriko Komitsu, Michiko Aihara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23182761     DOI： 10.1016/j.jdermsci.2012.11.001

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN： 0923-1811            Impact factor:   4.563


× No keyword cloud information.
  20 in total

1.  Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir.

Authors:  Jesper F Højen; Thomas A Rasmussen; Karen Lise D Andersen; Anni A Winckelmann; Rune R Laursen; Jesper D Gunst; Holger J Møller; Mayumi Fujita; Lars Østergaard; Ole S Søgaard; Charles A Dinarello; Martin Tolstrup
Journal:  Mol Med       Date:  2015-04-14       Impact factor: 6.354

2.  Modulation of IL-37 expression by triptolide and triptonide in THP-1 cells.

Authors:  Lingge He; Zhuangyan Liang; Fuqian Zhao; Lifei Peng; Zhangquan Chen
Journal:  Cell Mol Immunol       Date:  2014-10-13       Impact factor: 11.530

3.  Downregulated interleukin 37 expression associated with aggravation of intervertebral disc degeneration.

Authors:  Zhong-Yuan Wan; Zhen Sun; Fang Song; Yu-Fei Chen; Wei-Lin Zhang; Hai-Qiang Wang; Zhuo-Jing Luo
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

4.  Common genetic heterogeneity of human interleukin-37 leads to functional variance.

Authors:  Jingjing Yan; Yuling Zhang; Shimeng Cheng; Bin Kang; Jinbiao Peng; Xiaodan Zhang; Meichun Yuan; Wenqi Chu; Wen Zhang; Jiayin Shen; Shuye Zhang
Journal:  Cell Mol Immunol       Date:  2016-09-26       Impact factor: 11.530

5.  Mannose-capped Lipoarabinomannan from Mycobacterium tuberculosis induces IL-37 production via upregulating ERK1/2 and p38 in human type II alveolar epithelial cells.

Authors:  Zhen Huang; Gao Wei Zhao; Chun Hai Gao; Xiu Wen Chi; Tao Zeng; Yan Wei Hu; Lei Zheng; Qian Wang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 6.  Suppression of innate inflammation and immunity by interleukin-37.

Authors:  Charles A Dinarello; Claudia Nold-Petry; Marcel Nold; Mayumi Fujita; Suzhao Li; Soohyun Kim; Philip Bufler
Journal:  Eur J Immunol       Date:  2016-05       Impact factor: 5.532

7.  IL-37b alleviates endothelial cell apoptosis and inflammation in Kawasaki disease through IL-1R8 pathway.

Authors:  Chang Jia; Yingzhi Zhuge; Shuchi Zhang; Chao Ni; Linlin Wang; Rongzhou Wu; Chao Niu; Zhengwang Wen; Xing Rong; Huixian Qiu; Maoping Chu
Journal:  Cell Death Dis       Date:  2021-06-03       Impact factor: 8.469

8.  Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity.

Authors:  Bingni Chen; Kunzhao Huang; Liang Ye; Yanqun Li; Jiawei Zhang; Jinshun Zhang; Xinmin Fan; Xiaokai Liu; Li Li; Jinxia Sun; Jing Du; Zhong Huang
Journal:  J Transl Med       Date:  2015-01-28       Impact factor: 5.531

9.  Transcriptome and ultrastructural changes in dystrophic Epidermolysis bullosa resemble skin aging.

Authors:  Jenny S Breitenbach; Mark Rinnerthaler; Andrea Trost; Manuela Weber; Alfred Klausegger; Christina Gruber; Daniela Bruckner; Herbert A Reitsamer; Johann W Bauer; Michael Breitenbach
Journal:  Aging (Albany NY)       Date:  2015-06       Impact factor: 5.682

10.  Plasma Interleukin-37 Is Elevated in Patients with Rheumatoid Arthritis: Its Correlation with Disease Activity and Th1/Th2/Th17-Related Cytokines.

Authors:  Ting Xia; Xing-feng Zheng; Bao-hua Qian; He Fang; Jun-jie Wang; Lan-ling Zhang; Ya-fei Pang; Ju Zhang; Xiao-qing Wei; Zhao-fan Xia; Dong-bao Zhao
Journal:  Dis Markers       Date:  2015-09-06       Impact factor: 3.434
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.